Claudia Proto

机构：Tumori Foundation, Fondazione IRCCS Istituto Nazionale dei Tumori · ORCID：0000-0003-0287-9787

发表论文 318 篇 · 总被引 4352 次 · h-index 33

代表论文

• APOLLO11: a bio-data-driven model for clinical and translational research in lung cancer (2026 · npj Precision Oncology · 被引 2)
• Clinical usability of an explainable AI decision support tool and evaluation of multimodal models in NSCLC (2026 · Nature Medicine · 被引 1)
• Composite clinical scores in real-world extensive-stage small-cell lung cancer patients treated with chemo-immunotherapy (2026 · Tumori Journal)
• Leave No Data Behind: Exploring a new paradigm in oncology with foundation models and large language models (2026 · Cell Reports Medicine)
• A plain language summary of the SAVANNAH study: savolitinib plus osimertinib in patients with EGFR-mutated advanced non-small cell lung cancer with MET overexpression and/or amplification whose cancer had grown or spread on osimertinib (2026 · Figshare)
• A plain language summary of the SAVANNAH study: savolitinib plus osimertinib in patients with EGFR-mutated advanced non-small cell lung cancer with MET overexpression and/or amplification whose cancer had grown or spread on osimertinib (2026 · Figshare)